 |
Atara Biotherapeutics
Last updated: January 29, 2024
Isaac Ciechanover, CEO & President
Country: USA | Funding: $499.8M (+)
Website: http://www.atarabio.com/
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, multiple sclerosis (MS).
Website: http://www.atarabio.com/
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, multiple sclerosis (MS).
